ANSTO annual report 2008-09
| dc.contributor.author | Australian Nuclear Science and Technology Organisation | en_AU |
| dc.date.accessioned | 2010-10-06T04:59:37Z | en_AU |
| dc.date.available | 2010-10-06T04:59:37Z | en_AU |
| dc.date.issued | 2009 | en_AU |
| dc.date.statistics | 2009 | en_AU |
| dc.description.abstract | ANSTO is Australia’s national nuclear research and development organisation and is the centre of Australian nuclear expertise. It is part of the Australian Government portfolio of Innovation, Industry, Science and Research. ANSTO undertakes research in the applications of nuclear science and technology and delivers specialised advice, scientific services and products to government, universities, other research organisations, international organisations and businesses in areas as diverse as mining and radiopharmaceuticals. About one-third of ANSTO’s staff are involved in research. The balance are in business services, operations and support to government roles. ANSTO operates Australia’s nuclear research reactor OPAL which is used to produce radioactive products for use in medicine and industry, as a source of neutron beams for scientific research and to irradiate silicon for semiconductor applications. ANSTO’s research infrastructure also includes accelerators, cyclotrons and associated instruments as well as workshops, pilot plants and specialist laboratories. ANSTO’s research infrastructure is used extensively by other members of the Australian and international research communities including researchers from universities, other science and technology organisations and industry. ANSTO also manages the Access to Major Research Facilities Program (AMRFP), which provides Australian researchers with access to major international facilities. ANSTO’s main campus is located 40 km south west of Sydney’s central business district, occupies 70 hectares and is surrounded by a 1.6 km buffer zone. The organisation’s functions are prescribed by the Australian Nuclear Science and Technology Organisation Act 1987 (ANSTO Act) and are translated into action through its strategic and annual planning process. | en_AU |
| dc.identifier.govdoc | 2783 | en_AU |
| dc.identifier.issn | 1031-6655 | en_AU |
| dc.identifier.uri | http://apo.ansto.gov.au/dspace/handle/10238/2623 | en_AU |
| dc.language.iso | en | en_AU |
| dc.publisher | Australian Nuclear Science and Technology Organisation | en_AU |
| dc.relation.ispartofseries | Annual Report | en_AU |
| dc.subject | ANSTO | en_AU |
| dc.subject | Progress report | en_AU |
| dc.subject | OPAL Reactor | en_AU |
| dc.subject | Cyclotrons | en_AU |
| dc.subject | Australia | en_AU |
| dc.subject | Radiopharmaceuticals | en_AU |
| dc.title | ANSTO annual report 2008-09 | en_AU |
| dc.type | External Report | en_AU |